Cargando…

Comment on comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis

Detalles Bibliográficos
Autores principales:	Wu, Jiangfeng, Ge, Lifang, Chen, Qiaoqian, Zhao, Anli, Guo, Yinghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347041/ https://www.ncbi.nlm.nih.gov/pubmed/35928734 http://dx.doi.org/10.21037/atm-22-323

Ejemplares similares

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients—reply letter
por: Xu, Yalan, et al.
Publicado: (2022)

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis
por: Xu, Yalan, et al.
Publicado: (2021)

Outcomes of the Next In Vitro Fertilization Cycle in Women with Polycystic Ovary Syndrome after a Failed In Vitro Maturation Attempt
por: Guo, Wei, et al.
Publicado: (2023)

Do Basal Luteinizing Hormone and Luteinizing Hormone/Follicle- Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome
por: Selçuk, Selçuk, et al.
Publicado: (2016)

Comment on the selection of the fixed or random effect model in a study
por: Sun, Yue, et al.
Publicado: (2022)

Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders”
por: Orvieto, Raoul
Publicado: (2015)

Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization
por: Li, Yu, et al.
Publicado: (2018)

The Boosting Effects of Melatonin on the In Vitro Fertilization (IVF) of Women with Polycystic Ovary Syndrome
por: Pilehvari, Shamim, et al.
Publicado: (2023)

Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome
por: Ma, Rujun, et al.
Publicado: (2023)

Polycystic ovary syndrome. Are we overlooking something?
por: Tekin, Abdullah
Publicado: (2016)

Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Is neostigmine safe and effective for neuromuscular blockade reversal in patients recovering from general anesthesia?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

The Effect of Sperm DNA Fragmentation on In Vitro Fertilization Outcomes for Women With Polycystic Ovary Syndrome
por: Wang, Huan, et al.
Publicado: (2022)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Reply to: Hyperprolactinemia and Hirsutism in Patients without Polycystic Ovary Syndrome
por: Saceda-Corralo, David, et al.
Publicado: (2017)

COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

Fertility achieved through in vitro fertilization in a male patient with 48,XXYY syndrome
por: Liu, De-Feng, et al.
Publicado: (2018)

Impact of adenomyosis on the outcome of in vitro fertilization
por: Qin, Yaoqin, et al.
Publicado: (2023)

Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
por: Figen Turkcapar, Ayse, et al.
Publicado: (2013)

Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
por: Eftekhar, Maryam, et al.
Publicado: (2016)

Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer
por: Lin, Hai-Yan, et al.
Publicado: (2019)

The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization
por: Jin, Yue, et al.
Publicado: (2019)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome
por: Vuong, Lan N., et al.
Publicado: (2020)

Polycystic ovary syndrome and arrhythmic risk: the role of comorbidities and the prevalence of interatrial block
por: Russo, Vincenzo, et al.
Publicado: (2016)

Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Comment on “Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?”
por: Chetan, Sahni, et al.
Publicado: (2017)

Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis
por: Yang, Liu, et al.
Publicado: (2023)

Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome
por: Chen, Ya, et al.
Publicado: (2017)

Association of Polycystic Ovary Syndrome Phenotypes With Adverse Pregnancy Outcomes After In-Vitro Fertilization/Intracytoplasmic Sperm Injection
por: Wang, Qiumin, et al.
Publicado: (2022)

Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment
por: Seok, Hyun Ha, et al.
Publicado: (2016)

Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
por: Ho, V. N. A., et al.
Publicado: (2018)

Response to: Comment on “Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation?”
por: Vaz, George Queiroz, et al.
Publicado: (2017)

Fertility Treatment Options for Women With Polycystic Ovary Syndrome
por: Sawant, Shital, et al.
Publicado: (2019)

The effect of follicular fluid selenium concentration on oocyte maturation in women with polycystic ovary syndrome undergoing in vitro fertilization/Intracytoplasmic sperm injection: A cross-sectional study
por: Mahsa Poormoosavi, Seyedeh, et al.
Publicado: (2021)

Comparison of In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycle Outcome in Patients with and without Polycystic Ovary Syndrome: A Modified Poisson Regression Model
por: Almasi-Hashiani, Amir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1c903looifruq2tjagr02aifq